
There is currently just 1 FDA-approved therapy for women suffering from dysfunction. What's driving the disparity?

There is currently just 1 FDA-approved therapy for women suffering from dysfunction. What's driving the disparity?

Sustained virological response with the treatment of HCV infection is associated with reduced mortality from extrahepatic complications, accoridng to a new study.

Why obstetricians and gynecologists need to consider the stigmas and telling signs of sexual dysfunction in female patients.

Prenatal exposure to the antiepileptic drug valproate is associated with increased risk for ADHD independent of its link to congenital malformations.

While the absolute risk of therapy-related blood cancers is low, the treatment is often intensive and linked to substantial morbidity.

A new survey study found that less than half of food allergies reported by adults have actually been diagnosed by a physician.

Antiepileptic drug levels that remain subtherapeutic—despite the correct dose and proper adherence—can improve with adjustment for pharmacokinetics.

A large Asian population study supports the link between HCV and parkinsonism in that region, and associated treating HCV with reduced risk.

The phase 3 CAMP-1 and CAMP-2 clinical trials evaluating VP-102 for the treatment of molluscum contagiosum demonstrated clinical and statistical significance.

In a 10-patient study, sutimlimab halted the destruction of red blood cells in patients with cold agglutinin disease.

Common infusion-associated adverse reactions with ocrelizumab for multiple sclerosis were substantially reduced with strategic premedication.

In theory, the combination of ART and PrEP would be enough to virtually eradicate HIV. In the real world, they’re falling well short.

Candidate vaccines for respiratory syncytial virus may also impact pediatric asthma and wheezing, but the required sample sizes are too large for a clinical trial.

A sham-controlled trial demonstrated that a novel at-home administration of transcranial stimulation reduced fatigue in multiple sclerosis.

The FDA has approved dasatinib (Sprycel) in combination with chemotherapy for the treatment of pediatric patients with newly diagnosed Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL).

The polio-like AFM is an emerging health concern, with outbreaks documented since 2012.

Overall, a new Florida State study found that 13-17 year-olds are behind all children in influenza vaccination rates.

The Pediatric Asthma Risk Score could improve on the track record of the Asthma Predictive Index, which in the past has been shown to poorly predict who would develop the condition.

A single blood eosinophil measurement may not be adequate for determining whether an asthma patient can have elevated blood eosinophils.

MD Magazine's most popular stories this year ranged from new clinical insights, to physician-submitted columns, to perspectives on burnout in the workplace.

Higher incidences of epilepsy in children with congenital heart disease prompted a neurocardiology team to call for increased perioperative EEG monitoring.

The CDC found that "provider-advised deferral" of HIV antiretroviral therapy occurring less, but that US still far from goal of universal prescribing.

Modeling depicts scenarios of PrEP averting larger number, but smaller percentage of HIV infections in black than white at-risk adolescent males.

New research suggests that more healthy people than previously thought have genetic variants associated with disease.

Investigators found significant differences among patient income quartile zip codes, as well as different age cohorts.

Anti-VEGF injection therapy is the proven choice of care for AMD and DME. Still, concerns about dosing, costs, and convenience persist into 2019.

Developed as part of a joint partnership between Sanofi and Merck, Vaxelis' commercial supply is not expected until 2020.

New research confirms the apparent link between schistosomiasis and risk of HIV transmission and acquisition.

The classic Fabry disease phenotype in men is almost exclusively marked by anti-agalsidase antibody development, despite having no clear clinical impact.

Researchers studied patients with hepatitis C in order to find out the relationship between immune activation and chronic fatigue.